FDA guidelines would expand access to unapproved drugs

12/11/2006 | NYTimes.com

The FDA proposed new guidelines for releasing unapproved drugs for patients who have no other options for treating life-threatening conditions. The proposed guidelines say drugs could be available during all stages of development, including initial, Phase I testing.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations